Table of Contents
ToggleIf you want to become a top PCD pharma franchise, you should start by learning about the industry and building your network in the field.
You can also ask for our franchise to be the top PCD pharma franchise company in India.
PCD pharma franchise industry is evolving at a rapid pace. According to a report by Research Update, India’s pharma industry will grow from $263 million in 2016 to $6 billion by 2023.
There are a few reasons why a pharma franchise is attractive–
# First, they come with a proven product offering and revenue stream.
# Second, they can be highly scalable and offer a lot of flexibility in terms of location, employee size and pay, etc.
# Third, they are very stable businesses that are unlikely to experience huge swings in revenue due to changing regulations or product trends.
# Fourth, they provide access to large customer bases and brand name recognition.
# Fifth, they tend to have strong balance sheets that can help finance growth.
The PCD pharma franchise industry is also witnessing an accelerating growth trajectory and is poised to become one of the most robust and large-scale pharmaceutical markets in India.
India is one of the world’s largest pharmaceutical markets. With a population of over 1.3 billion, India is becoming the world’s second-largest consumer of drugs.
Demographic changes, rising incomes and the increasing prevalence of chronic diseases such as diabetes, cancer drives the growth of the pharma sector.
Rapid urbanization and an expanding middle class have increased the demand for both prescription and over-the-counter medications. There are number of other growth factors that support the industry.
The government has also been recognizing the importance and has taken a number of initiatives to boost this sector.
The pharma franchise sector is experiencing a boom due to increasing demand, favourable demographics and an increasing need for medicines.
The Indian healthcare system is also witnessing an increase in demand for medicines.
Demand is through an aging population, a rising number of cancer patients and an increasing prevalence of non-communicable diseases.
Non-communicable diseases like diabetes, cardiovascular disorders and mental health disorders contributes more in demand.
Moreover, the government of India has introduced several policies to boost the Indian pharma industry.
For instance, the Indian government has waived off the customs duty for several medicines and has also reduced the threshold for import of certain drugs.
Distribution channel strategy in PCD pharma business is significant in the battle to win distributors and consumers.
In segments such as OTC or herbal, channel strategy is a core part of the overall marketing plan.
The way consumers access products, the services and promotions deployed, the relationship with distributors and the impact of these are of core considerations.
However, distribution channel strategy had often been overlooked in the past.
Now a mix of activities to support product differentiation, planning the approach to the components of channel carefully can result in gaining the loyalty of distributors and doctors.
A more accurate definition includes the management of three key components:
The Indian pharma industry will grow rapidly over the next few years.
This is due to a number of factors including increasing demand for medicines, favourable demographics and the increasing prevalence of chronic diseases, such as diabetes and cancer.
To drive the growth of the industry and be the top PCD pharma franchise, companies in this sector are also focusing on new molecule products and expansion of distribution channels.
These key strategies are expected to further strengthen this PCD pharma franchise sector.